Table 1.
Subjects' clinical and demographic characteristics
| Subjects (n = 55) | |
|---|---|
| Male gender | 23 (41.8) |
| Age (years) | 58 ± 9 |
| Indeterminate form | 16 (29) |
| Cardiac form without ventricular dysfunction | 16 (29) |
| Cardiac form with ventricular dysfunction | 23 (42) |
| NYHA III ou IV | 17 (30.9) |
| Hypertension | 39 (70.9) |
| Diabetes | 8 (14.5) |
| Current smoking | 15 (27.3) |
| Hypercholesterolemia | 23 (41.8) |
| RBBB | 27 (49.1) |
| Hemoglobin (g/dl) | 14.0 ± 0.97 |
| Creatinin (mg/dl) | 0.87 ± 0.16 |
| LVEF (%) | 53.7 ± 15.4 |
| LVESV (ml) | 79.1 ± 65.4 |
| LVEDV (ml) | 177.3 ± 80.6 |
| LVmass (g) | 172.8 ± 57.3 |
| Myocardial fibrosis (%) | 9.4 (2.2-17.3)* |
Data are expressed as number (percentage) for categorical variables, and as mean ± SD or median (interquartile interval) for continuous variables; NYHA: New York Heart Association CMR: RBBB: Right bundle-branch block; LVEF: Left ventricular ejection fraction; LVESV: Left ventricular end-systolic volume; LVEDV: Left ventricular end-diastolic volume; LV: Left ventricular mass.
*
n = 40 (delayed enhancement cardiac magnetic resonance).